Skip Navigation LinksHome > April 2006 - Volume 25 - Issue 4 > SAFETY AND IMMUNOGENICITY OF LIVE VARICELLA VIRUS VACCINE IN...
Pediatric Infectious Disease Journal:
doi: 10.1097/01.inf.0000207492.97867.15
Brief Reports

SAFETY AND IMMUNOGENICITY OF LIVE VARICELLA VIRUS VACCINE IN CHILDREN WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE 1

Armenian, Saro H. DO*‡; Han, Jin Young MD, PhD*‡; Dunaway, Theresa M. RN†‡; Church, Joseph A. MD†‡

Collapse Box

Abstract

Live varicella virus vaccine was administered to 10 stable human immunodeficiency virus type 1 (HIV-1)-infected children. Subjects were monitored for adverse reactions, HIV-1 plasma levels, CD4+ T cell counts and immune responses. The vaccine was well-tolerated. Varicella-zoster virus-specific lymphocyte proliferative responses were detected in all subjects by 4 weeks and in 9 of 10 subjects 1 year after vaccination.

© 2006 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.